Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization

Susan S Huang1, Richard Platt

  • 1Channing Laboratory, Brigham and Women's Hospital, Division of Infectious Diseases, Boston, MA 02115 , USA. sshuang@partners.org

Insights

Many patients newly identified with methicillin-resistant Staphylococcus aureus (MRSA) develop severe infections after hospital discharge. Prolonged follow-up is essential to accurately assess MRSA sequelae risk.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Public Health

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant healthcare challenge.
  • Previous studies on MRSA sequelae have limited follow-up to the inpatient period.
  • The post-discharge risk of MRSA-associated complications remains under-evaluated.

Purpose of the Study:

  • To determine the 18-month risk of MRSA infection in adult inpatients newly identified as MRSA carriers.
  • To characterize the severity and sites of subsequent MRSA infections.
  • To assess the proportion of MRSA infections manifesting after hospital discharge.

Main Methods:

  • Prospective observational study.
  • Inclusion of 209 adult inpatients newly identified as harboring MRSA.
  • 18-month follow-up to identify subsequent MRSA infections.

Main Results:

  • 29% of patients (60/209) developed subsequent MRSA infections.
  • Subsequent infections were often severe, including bacteremia (28%) and pneumonia (56%).
  • 49% of new MRSA infections (44/90) manifested after hospital discharge, often at new sites (80%).

Conclusions:

  • A substantial proportion of patients newly identified with MRSA develop severe infections post-discharge.
  • MRSA sequelae risk assessment necessitates extended follow-up beyond hospitalization.
  • Understanding post-discharge MRSA infection patterns is crucial for patient management and public health strategies.

Related Concept Videos

Mismatch Repair01:48

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.The Mutator Protein Family Plays a Key Role in DNA Mismatch RepairThe human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...